文献速递生殖医学妇科产科

铁过载疾病对成人性腺功能、生殖与性健康的综合综述

Iron overload disorders in adults: a comprehensive review of gonadal function, reproductive, and sexual health.
PubMed 文献 · Hum Reprod Update · 2026-01-01

本综述系统检索至2025年5月的文献,整合铁过载疾病对男女生殖功能的影响。分析显示男性性腺功能减退患病率达47.0%,女性原发性闭经45.7%、继发性闭经20.0%,月经初潮延迟至14.4±2.1岁。妊娠中ART需求约20%、流产率11.2%、剖宫产率约80%。早期铁螯合治疗可预防内分泌并发症,但对已发生的生殖功能障碍逆转证据有限。

要点

  • 铁过载患者性腺功能减退常见,男性患病率47.0%,女性闭经比例高。
  • 男性精子异常包括无精子症17.6%和其他异常37.5%,女性初潮延迟。
  • 妊娠需ART约20%,流产率11.2%,剖宫产率约80%,早产和低出生体重常见。

核心结论

  • 铁过载疾病显著损害男女生殖功能,性腺功能减退是最常见内分泌并发症。
  • 早期铁螯合治疗可预防内分泌并发症,但对已建立的生殖功能障碍逆转证据有限。
  • 需标准化性腺筛查和整合临床框架以保护生殖健康。

研究设计与样本

  • 系统综述,检索PubMed、Scopus和Web of Science截至2025年5月。
  • 定量合成汇总了性腺功能减退、精液异常、闭经、初潮年龄和妊娠结局的患病率数据。
  • 分析纳入1201名男性和2134名女性,以及3536例妊娠。

主要发现

  • 男性性腺功能减退患病率47.0%;评估精子生成者中无精子症17.6%、其他精子异常37.5%。
  • 女性原发性闭经45.7%、继发性闭经20.0%,初潮平均年龄延迟至14.4±2.1岁。
  • 妊娠中ART需求约20%,流产率11.2%,剖宫产率约80%。
  • 平均分娩孕周37.1±3.1周,平均出生体重2.64±0.68 kg。
  • 铁诱导性腺功能减退是最常见内分泌并发症,性功能障碍(如勃起功能障碍)常伴随发生。

关键数值与推荐

  • 男性性腺功能减退患病率47.0%(1201名男性)。
  • 女性原发性闭经45.7%、继发性闭经20.0%(2134名女性)。
  • 初潮平均年龄14.4±2.1岁。
  • 3536例妊娠中ART约20%、流产11.2%、剖宫产约80%。
  • 平均分娩孕周37.1±3.1周,平均出生体重2.64±0.68 kg。

临床怎么用

  • 对铁过载患者进行标准化性腺筛查,包括性激素和精液/排卵评估。
  • 早期启动铁螯合治疗以预防内分泌并发症。
  • 提供生育力保存咨询和生殖健康咨询。
  • 妊娠期多学科管理,关注ART需求、流产和剖宫产风险。

局限性

  • 女性性健康完全未被研究。
  • 支持逆转已建立生殖功能障碍的证据有限。
  • 研究设计、诊断标准和管理缺乏共识指南。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Iron overload (IO) disorders, including thalassaemias, hereditary haemochromatosis, and transfusion-dependent anaemias, represent a growing clinical challenge with widespread systemic implications. Reproductive dysfunction remains severely underappreciated despite its high prevalence. Hormonal changes due to iron toxicity are frequently reported, yet are seldom the focus of reproductive medicine, causing fragmented knowledge, inconsistent clinical approaches, and a lack of consensus guidelines. OBJECTIVE AND RATIONALE: This review synthesizes evidence on the impact of IO on male and female reproductive function, including gonadal dysfunction, impaired fertility, sexual dysfunction, and endocrine-metabolic complications. By addressing gaps in study design, diagnostic criteria, and management, we aim to provide the first comprehensive, expert-driven synthesis on the topic, integrating clinical, translational, and mechanistic insights to establish a structured framework for future research and patient care. SEARCH METHODS: A systematic literature search was conducted across PubMed, Scopus, and Web of Science, including studies up to May 2025. Search terms included 'iron overload', 'thalassemia', 'hemochromatosis', 'hypogonadism', 'fertility', 'spermatogenesis', 'ovarian insufficiency', and 'pregnancy'. Quantitative synthesis involved pooling data on prevalence rates of hypogonadism, semen abnormalities, primary and secondary amenorrhoea, age at menarche, and pregnancy outcomes. OUTCOMES: Gonadal dysfunction primarily arises from iron deposition within the hypothalamic-pituitary-gonadal axis, coupled with oxidative damage to Leydig and Sertoli cells in males, disrupting testosterone synthesis and spermatogenesis, and to ovarian follicles and granulosa cells in females, causing reduced ovarian reserve and altered hormonal signalling. Iron-induced hypogonadism is the most frequent endocrine complication, significantly impacting reproductive health and quality of life. Our analysis of 1201 men and 2134 women indicated hypogonadism, reflecting impaired testicular endocrine function, in 47.0% of men; among those specifically assessed for spermatogenesis, over half presented azoospermia (17.6%) or other sperm abnormalities (37.5%). In women, primary amenorrhoea was reported in 45.7%, secondary amenorrhoea in 20.0%, and the weighted mean age at menarche was delayed (14.4 ± 2.1 years). Sexual dysfunction, notably erectile dysfunction, commonly accompanies hypogonadism, further impairing quality of life. Female sexual health has not been investigated at all. Pregnancy is increasingly achievable, but remains clinically challenging. Across 3536 reviewed pregnancies, ART was required in ∼20%, miscarriage occurred in 11.2%, and caesarean section was used in ∼80%. Mean gestational age at delivery was 37.1 ± 3.1 weeks, and mean birth weight was 2.64 ± 0.68 kg. Besides gonadal damage (direct or pituitary-related), systemic iron-related endocrine and metabolic disturbances, including hypothyroidism, growth hormone deficiency, diabetes mellitus, and cardiovascular disease, further aggravate reproductive impairments. Although effective iron chelation therapy reduces the systemic iron burden and is effective in preventing endocrine complications when initiated early, evidence supporting the reversal of established reproductive dysfunction remains limited, highlighting the need to optimize iron control from a young age to preserve reproductive health. WIDER IMPLICATIONS: This review underscores the critical need for standardized gonadal screening to facilitate personalized reproductive care and early intervention in subjects with IO disorders. We propose an integrated clinical framework, combining early endocrine monitoring, fertility preservation protocols, and reproductive counselling. Future multidisciplinary research should prioritize prospective studies with clearly defined reproductive endpoints and explore optimized chelation strategies to safeguard reproductive potential. Addressing these gaps will fundamentally reshape clinical management, bridging haematology, endocrinology, and reproductive medicine.

来源:Hum Reprod Update,查看原文。版权归原作者所有。

引用

  1. Carlomagno F, Tenuta M, Sansone A, et al. Iron overload disorders in adults: a comprehensive review of gonadal function, reproductive, and sexual health. Hum Reprod Update. 2026. PMID: 42101252. doi:10.1093/humupd/dmag010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。